Nurse consultant named president-elect of UK Oncology Nursing Society

Dr Jo Bird, nurse consultant at Sheffield Teaching Hospitals NHS Trust and honorary senior lecturer, Division of Clinical Medicine, University of Sheffield, has been elected president-elect of the UK Oncology Nursing Society (UKONS).

Jo Bird (c) Sheffield Teaching Hospitals NHS Trust

Jo Bird (c) Sheffield Teaching Hospitals NHS Trust

Bird takes up the post with immediate effect and will support incoming president Dr Mary Tanay (Royal Berkshire NHS Foundation Trust) for a period of two years before becoming president herself from December 2027. 

She said: ‘It is a great privilege to be elected president elect of UKONS. The charity provides educational opportunities for cancer nurses to improve the outcomes of people with cancer. This year has been the 20th anniversary and the celebrations have showcased the supportive community that has developed and how standards for clinical practice have been implemented. I look forward to working with colleagues from across the UK to build on these achievements.'

Bird is a nurse consultant in melanoma and immunotherapy late effects at Sheffield Teaching Hospitals NHS Foundation Trust and an honorary research fellow at the University of Sheffield.

She previously worked as clinical research nurse across a variety of cancer sites and early phase trials and continues to maintain a clinical academic career having completed an NIHR Clinical Doctoral Research Fellowship.

Chief data officer to leave NHS England

Chief data officer to leave NHS England

By Liz Wells 02 February 2026

Ming Tang, chief data and analytics officer at NHS England, has announced she is to leave in April.

Hospital orders review of services following concerns

By Lee Peart 02 February 2026

Cambridge University Hospitals (CUH) NHS Foundation Trust has ordered a review of neurosciences services at Addenbrooke's Hospital following concerns.

NHS App to offer greater access to breakthrough trials for rare cancer patients

By Liz Wells 02 February 2026

DHSC has revealed that rare cancer patients will receive faster access to clinical trials through the NHS App.


Popular articles by Lee Peart